|Bid||5.00 x 1100|
|Ask||0.00 x 1400|
|Day's range||5.55 - 6.38|
|52-week range||5.31 - 35.00|
|Beta (5Y monthly)||2.05|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||28 Aug 1996|
|1y target est||N/A|
VIENNA, Va., December 22, 2021--CEL-SCI reports fiscal 2021 financial results and clinical & corporate developments.
VIENNA, Va., October 22, 2021--CEL-SCI Corporation completes commercial-scale buildout of Multikine manufacturing facility.
VIENNA, Va., August 16, 2021--CEL-SCI Corporation reports third quarter fiscal 2021 financial results.